Article
Fluorescence optical imaging is helpful in the decision for rituximab (RTX) re-therapy in patients with rheumatoid arthritis
2020-03-23
Abstract excerpt
<h4>Objective: </h4> To evaluate the ability of fluorescence optical imaging (FOI) Xiralite® in the prediction of RTX re-therapy in rheumatoid arthritis (RA) patients - in comparison to clinical, laboratory and musculoskeletal ultrasound (US) parameters. Patients and methods Patients with established RA were prospectively followed over one year by DAS28, patient’s global disease activity (VAS 0-100 mm), CRP and ES...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e84b2962-f7e6-5549-8121-1c1205c37f32
- DOI
- 10.21203/rs.3.rs-18466/v1
